Publications by authors named "Masahiro Kamimoto"
Article Synopsis
- - The study focused on identifying risk factors for COVID-19 deterioration in unvaccinated individuals under 65 years old during Japan's fifth wave, as many cases occurred in this demographic.
- - Researchers analyzed data from 1,675 patients in Fukushima and created predictive scores to estimate deterioration risk using logistic regression, highlighting significant factors like age, body temperature, oxygen saturation, and comorbidities (diabetes, obesity).
- - The findings indicated that 8.6% of patients experienced deterioration, with predictors including older age, male gender, and various health issues; two risk scores were developed, DOATS and DOAT, to assess patient risk.
Objectives: The aim of this study was to examine the performance of a convolutional neural network (CNN) combined with exponentiating each pixel value in classifying benign and malignant lung nodules on computed tomography (CT) images.
Materials And Methods: Images in the Lung Image Database Consortium-Image Database Resource Initiative (LIDC-IDRI) were analyzed. Four CNN models were then constructed to classify the lung nodules by malignancy level (malignancy level 1 vs.
Article Synopsis
- A study was conducted to evaluate the efficacy of molnupiravir in hospitalized patients with mild-to-moderate COVID-19 during the Omicron variant surge in Fukushima, Japan, by comparing outcomes between those who used the drug and those who did not.
- After matching molnupiravir users with non-users based on similar characteristics, results showed that the clinical deterioration rate was significantly lower for users (3.90%) compared to non-users (8.40%).
- Multivariate analysis indicated that treatment with molnupiravir independently reduced the risk of deterioration in COVID-19 patients after hospitalization during the Omicron variant phase.
Article Synopsis
- - The study assessed the effectiveness of the monoclonal antibody treatment casirivimab-imdevimab for mild-to-moderate COVID-19 patients during the Delta variant surge in Fukushima, Japan, enrolling 949 patients.
- - Casirivimab-imdevimab users were generally older and had higher rates of health issues like obesity, hypertension, and higher body temperatures compared to non-users.
- - The findings show that receiving casirivimab-imdevimab significantly reduced the risk of clinical deterioration in hospitalized patients, highlighting its potential benefit during COVID-19 hospitalization (odds ratio 0.448).
We report a case of acute-onset type 1 diabetes due to combined application of nivolumab and intravesical Bacillus Calmette-Guérin (BCG). An 84-year-old woman underwent lung resection for pulmonary squamous cell carcinoma. She had been treated for type 2 diabetes and later experienced lung cancer recurrence.
View Article and Find Full Text PDF